Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Zeo ScientifiX (ZEOX) Cash & Equivalents (2016 - 2026)

Zeo ScientifiX (ZEOX) has 11 years of Cash & Equivalents data on record, last reported at $221000.0 in Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 66.36% year-over-year to $221000.0; the TTM value through Oct 2025 reached $221000.0, down 66.36%, while the annual FY2025 figure was $221000.0, 66.36% down from the prior year.
  • Cash & Equivalents reached $221000.0 in Q4 2025 per ZEOX's latest filing, down from $314000.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $3.8 million in Q4 2022 and bottomed at $29207.0 in Q3 2021.
  • Average Cash & Equivalents over 5 years is $743174.6, with a median of $587500.0 recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: tumbled 90.78% in 2021, then soared 3356.76% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $108570.0 in 2021, then skyrocketed by 3356.76% to $3.8 million in 2022, then tumbled by 53.21% to $1.8 million in 2023, then tumbled by 62.59% to $657000.0 in 2024, then tumbled by 66.36% to $221000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $221000.0 in Q4 2025, $314000.0 in Q3 2025, and $542000.0 in Q2 2025.